Home Novo Nordisk A/S (NVO) Receives Sell Rating from Zacks Investment Research
 

Keywords :   


Novo Nordisk A/S (NVO) Receives Sell Rating from Zacks Investment Research

2016-01-17 15:45:50| Biotech - Topix.net

's stock had its "sell" rating reissued by Zacks Investment Research in a research report issued to clients and investors on Sunday, MarketBeat.Com reports. According to Zacks, "Novo Nordisk's third-quarter 2015 results were strong with revenues increased on the back of robust performance from Victoza and Levemir as well as significant contributions from Tresiba and Saxenda.

Tags: research rating sell investment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.1115kg 50mm
14.11ONE PIECE BOX
14.11DAIWA OCEAN STAR 500
14.11fender jhon mayer blackone
14.11 Angel Touch Plus vol.3
14.11Strymon BigSky
14.11
14.11 TOUR B X 2
More »